DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.63 -0.06 (-0.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Cash & Current Investments (2017 - 2026)

Updated

DiaMedica Therapeutics (DMAC) posted Cash & Current Investments of $43.5 million for Q2 2026, up 44.8% from $30.04 million a year earlier but down 15.2% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, DiaMedica Therapeutics' Cash & Current Investments came in at $59.89 million, up 35.7% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
  • In prior years, DiaMedica Therapeutics' Cash & Current Investments was $44.15 million in FY2024 (-16.5%), $52.9 million in FY2023 (+57.9%), $33.5 million in FY2022 (-25.7%) and $45.11 million in FY2021 (+64.0%).
  • Quarterly Cash & Current Investments has run from a low of $28.66 million in Q1 2023 to a high of $59.89 million in Q4 2025 over five years.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last four quarters, with growth averaging 7.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2022, with growth of 80.5%; the weakest was Q2 2025, with a decline of 44.4%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $51.33 million (Q1 2026), $59.89 million (Q4 2025) and $55.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,147.74 Bn 1,116.33 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.22 Bn 556.08 Bn 17.30 Bn 17.23 Bn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn 6.57 Bn
4 Merck 357.93 Bn 312.30 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 301.67 Bn 265.66 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 264.02 Bn 237.70 Bn 12.86 Bn 4.90 Bn
7 Amgen 239.31 Bn 194.70 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.97 Bn 169.17 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 11.70 Bn
10 DiaMedica Therapeutics 450.29 Mn 240.24 Mn - 43.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.50 Mn
Mar 31, 2026 51.33 Mn
Dec 31, 2025 59.89 Mn
Sep 30, 2025 55.32 Mn
Jun 30, 2025 30.04 Mn
Mar 31, 2025 36.32 Mn
Dec 31, 2024 44.15 Mn
Sep 30, 2024 50.20 Mn
Jun 30, 2024 54.06 Mn
Mar 31, 2024 46.52 Mn
Dec 31, 2023 52.90 Mn
Sep 30, 2023 46.47 Mn
Jun 30, 2023 40.37 Mn
Mar 31, 2023 28.66 Mn
Dec 31, 2022 33.50 Mn
Sep 30, 2022 36.08 Mn
Jun 30, 2022 38.44 Mn
Mar 31, 2022 41.05 Mn
Dec 31, 2021 45.11 Mn
Sep 30, 2021 48.10 Mn
API Access

DiaMedica Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=DMAC&period=max&api_key=YOUR_API_KEY